Strategy Driven

JULY 13, 2011

Performance measurement typically drives much of the way a large company works. Supplementing profits with ROIC and revenue growth is a step in the right direction to ensure that the profits a business earns are actually creating value, not simply over-consuming capital that another company could better deploy.

ROIC 62

ROIC Balanced Scorecard Metrics McKinsey 62

Marshall Goldsmith

FEBRUARY 8, 2018

Thinkers50 – World’s Most Influential Management Thinkers. Called ‘The Academy Awards of Leadership’ by the Economist, Thinkers50 is the world’s most reliable resource for identifying, ranking and sharing the leading management ideas of our age. World authority on project management. Co-author: Predictable Magic.

Executive Coaching 70

Executive Coaching CEO Magazine Banking 70

Harvard Business Review

JULY 8, 2016

They’ve simply undercut Western competitors by offering cheaper prices. The first will be continued displacement by ever-more-competitive Chinese companies who compete on cost. This presents Western companies with a fresh challenge. They have been displacers, not disrupters. Drucker Forum 2016: The Entrepreneurial Society.

Business Model 13

Business Model Innovation Company Apparel 13

Harvard Business Review

SEPTEMBER 12, 2012

The study assembles considerable evidence about the hidden business model of major pharmaceutical companies: to devote most of their research budget to developing hundreds of drugs that provide few if any advantages over existing drugs and then market them heavily to doctors and patients.

Business Model 15

Business Model Company Pharmaceuticals Price 15

Harvard Business Review

MARCH 14, 2017

We believe these same measures can be successfully adopted and adapted by other companies in pharma and other sectors that seek to avert, or reverse, innovation stagnation. In a recent Gallup poll , the pharmaceutical industry was the most widely disliked private industry, ranking even lower than lawyers.

Innovation 13

Innovation Company Incentives Industry 13

Harvard Business Review

MARCH 27, 2018

“It’s no good fighting an election campaign on the facts,” Cambridge Analytica’s managing director told an undercover reporter, “because actually it’s all about emotion.” Facebook, Google, Amazon, and similar companies are “data-opolies.” James Graham/Getty Images. In the U.S.,

Company 14

Company Advertising Incentives Engineering 14

Harvard Business Review

MAY 26, 2016

That is good news for managers and investors. While a dynamic, competitive economy rewards innovative firms with high profits and punishes poor performers with low profits, sustained aggregate profits suggest, instead, that firms are able to get away with higher prices because competition is limited. Profits are up.

Pharmaceuticals 14

Pharmaceuticals Politics Price Chemicals 14

Harvard Business Review

NOVEMBER 8, 2018

Many companies struggle to deliver a consistent and easy buying experience for their customers. Consider the following scenario: A manager wants to purchase some computer software for her business. The analyst recommends a particular software company’s solution. gremlin/Getty Images. But then things begin to break down.

Marketing 14

Marketing Team Software Pharmaceuticals 14

Harvard Business Review

APRIL 16, 2012

To enhance financial flexibility, companies have been retaining unprecedented amounts of cash on their balance sheets, calling it "strategic" cash to distinguish it from the "operating" cash that is needed to run the business. high technology or pharmaceutical) that are investing in projects with uncertain long-range payoffs.

Company 14

Company Cost of Capital Finance Long-term 14

Strategy Driven

MARCH 18, 2011

The conventional wisdom about strategy may be leading your company astray. Achieving coherence requires a sharpness of focus that few companies have mastered. In this unpredictable economy, traditional approaches to strategy are a luxury most companies cannot afford. by Paul Leinwand and Cesare Mainardi. Let’s go after it.”

Resources 51

Resources Industry System Strategy 51

Harvard Business Review

DECEMBER 20, 2011

The Lipitor story seems to be about a managed end: the highly anticipated demise (due to the expiration of its patent last Nov. Apple use life-cycle management to explore a new way to drive the business and business model forward. Diplomat will sell mail-order branded Lipitor at generic prices. Both Pfizer and.

Disintermediation 16

Disintermediation Industry Pharmaceuticals Price 16

Harvard Business Review

MAY 31, 2018

The pharmaceutical company Valeant raised the price of Cuprimine — invented in 1956 and used to treat Wilson’s disease, a rare condition in which the body cannot process copper — from about $500 to about $24,000 for a 30-day supply, causing outrage from consumers. Insight Center. Competing in the Future.

CEO 8

CEO Short-term Long-term McKinsey 8

Harvard Business Review

APRIL 2, 2018

There is an abundance of high-quality comparative effectiveness data for pharmaceuticals, largely because of the drug approval process, but there’s less data on the value of other expensive investments into health, such as doctor visits and hospitalizations. (For

Health Care 8

Health Care Insurance Pharmaceuticals Incentives 8

The Practical Leader

APRIL 6, 2022

” Depending on how real or alive these passionate purposes are, they can rally and arouse people to work for, buy from, invest in, or partner with these companies. ” A financial services company: “ Helping our clients build their financial freedom and security.” And don’t delegate purpose to marketing.

Mintzberg 111

Mintzberg Pharmaceuticals Energy McKinsey 111

Harvard Business Review

DECEMBER 22, 2016

On December 7, Portland, Oregon, passed a law that will impose a surcharge on the local business taxes paid by corporations that operate in the city when the CEO’s compensation is 100 times or more the median earnings of the company’s employees. public corporations must file with the U.S.

CEO 8

CEO Black-Scholes Price Merton 8

Harvard Business Review

APRIL 4, 2018

Take United Airlines CEO Oscar Munoz, whose initial response to the violent removal of a fare-paying passenger from one of the company’s planes led to a public backlash. Or the notorious case of Martin Shkreli, the former CEO of Turing Pharmaceuticals, who failed to apologize for dramatically raising the price of a life-saving drug.

Creativity 15

Creativity Pharmaceuticals Learning-by-Doing Team 15

Harvard Business Review

MAY 7, 2015

A company is only as valuable as its customers and to gain or keep them, you have to do a specific job for them. “It’s a measure of how much value an individual customer, or customer segment, gets from using a company’s products or services,” says Avery. What is EVC? ” How do you calculate EVC?

Price 8

Price Venture Capitalist Incentives Cost 8

Harvard Business Review

JUNE 14, 2017

Information that would once have been proprietary — and premium-priced — is now widely available, for free. Some firms have managed it, in healthcare and in other arenas — think of QuintilesIMS as a source of pharmaceutical sales data, Nielsen as the authority on TV viewer habits, and the U.S. demographics.

Health Care 12

Health Care Levitt Competitive Advantage Pharmaceuticals 12

Harvard Business Review

MAY 24, 2012

Every large financial services company has instituted risk management, but that hasn't prevented risky behavior in the form of office politics and personality conflict — as the JP Morgan trading debacle has demonstrated. Risk management isn't exclusive to banking. And the pricing models.". "Oh, We can cover it.".

Merchandising 11

Merchandising Risk Management Supply Chain Retail 11

Harvard Business Review

MARCH 2, 2011

The days when you could make a living responding to companies' discovery of strategy, as in "Gosh, we gotta get ourselves one of those," are gone with the 1970s (or maybe the 1990s in the "developing world"). Strategy has triumphed, the installed base is huge, no self-respecting company would be without one. Monitor & Co.,

Consultative 16

Consultative Strategy McKinsey Porter 16

Harvard Business Review

DECEMBER 14, 2017

To be the change that many desire, these new mergers and acquisitions, and the others that will likely follow, must produce a higher-quality product for consumers (and satisfy physicians and other health professionals) at an affordable price. The answer is far from certain, and the uncertainties differ for the two mergers.

Health Care 8

Health Care System Insurance Pharmaceuticals 8

Harvard Business Review

JUNE 16, 2016

Yet, in the first quarter of 2016 the company sold only $17 million of Entresto in the U.S. by both insurance companies and cardiologists to a new and expensive drug (which costs more than $4,000 a year, compared to pennies a day for existing drugs). The test of a capability is not in management action but in management learning.

Planning 8

Planning Competitive Intelligence Pharmaceuticals Brand 8

Harvard Business Review

JANUARY 31, 2013

The new era will give manufacturing companies an opportunity to help their host economies in all of those areas; it will create high-skill jobs, particularly in design, big data, and other service roles, but not masses of production-line positions. All over the world, automakers are mastering new drive train technologies. but also the risks.

Globalization 11

Globalization Supply Chain Pharmaceuticals McKinsey 11

Harvard Business Review

SEPTEMBER 5, 2016

Its CEO, John Fallon, says of this approach, “It is by having a bigger impact on education — measured by expanding access and improving outcomes — that we will make Pearson a faster-growing and more sustainably profitable company.” ” Health care.

Incentives 8

Incentives Health Care Education Insurance 8

Harvard Business Review

SEPTEMBER 14, 2017

Most companies pay salespeople a combination of a salary, a commission, and a bonus for hitting a quota, putting a portion of their pay at risk. Within an industry or company, pay mix often varies across sales roles. Generally, it’s believed that an aggressive pay mix (i.e. Free sales come in two forms.

Motivation 8

Motivation Incentives Franchising Short-term 8

Harvard Business Review

MAY 5, 2016

Foreign companies, foreign governments, and Iranians expected to see improvements to Iran’s investment climate after implementing a nuclear deal and sanctions relief in the country. This slow pace of change has left many senior leaders at multinational companies frustrated and doubtful about Iran’s potential. For non-U.S.-based

Tourism 8

Tourism Banking Due Diligence Hotels 8

Harvard Business Review

JUNE 16, 2011

Investors grapple daily in an effort to figure out how to value companies whose accounting assets — things like land, capital, products, and licenses — don't adequately express their true market value. There is no line on the balance sheet for "ability to innovate" or "skill at managing brand."

Intangible Assets 16

Intangible Assets Analysis Pharmaceuticals Innovation 16

Harvard Business Review

SEPTEMBER 13, 2011

They put a great deal of emphasis on reporting and celebrating quarterly and yearly results — with the assumption that there is a huge upside to being perceived as a winning company. After all, positive results attract investors, raise stock prices, reinforce customers, draw talent, and more.

Short-term 14

Short-term Pharmaceuticals Long-term Maturity 14

Harvard Business Review

JANUARY 5, 2018

For example, in 2009 professors Brian Becker, Mark Huselid, and Richard Beatty estimated that in most companies less than 15% of jobs are what they call strategic positions and said management should focus “disproportionate investments” on finding A players for those jobs. Connectors in the middle.

McKinsey 8

McKinsey Human Resources Reputation Brand 8

Harvard Business Review

FEBRUARY 24, 2015

There is little consensus as to whether firms that find themselves spun off from other companies – either as new, standalone companies, or under the stewardship of new parent companies – perform better or worse than they did before. Does the business have a complete, balanced, and cohesive management team?

Chemicals 8

Chemicals How To Kahneman Reputation 8

Harvard Business Review

DECEMBER 18, 2014

Since that first foray into negotiating lower prices for commodity items, these coalitions have expanded their reach to include aggregation of supply purchases of items such as implantable medical devices, as well as drugs, capital purchases like CAT scan equipment and even electricity.

Health Care 9

Health Care Retail Mayo Pharmaceuticals 9

Harvard Business Review

OCTOBER 28, 2011

The story is a familiar one: A company's quarterly earnings fall significantly short of the investment community's expectations, and the CEO announces a restructuring, including a cut in R&D, to lower costs, regardless of the negative impact on the firm's long-term prospects.

CEO 10

CEO Short-term Long-term Restructuring 10

Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces. Merck and Co. Integration is key.

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8

Harvard Business Review

APRIL 28, 2011

I know a former CEO of a large beverage company who so loved direct consumer contact he couldn't contain himself at focus groups. We ask consumers the same kinds of questions that companies normally ask, but we use pictures. These cartoons have helped a company realize its pricing strategy was far too aggressive.

Loyalty 15

Loyalty Brand CEO Pharmaceuticals 15

Harvard Business Review

SEPTEMBER 7, 2015

First, there has never been a greater need for companies to learn new ways of doing things in response to a complex and dynamic business environment. They allow managers to suspend normal rules in an acceptable way and they provide an effective audiovisual medium for absorbing ideas.

Seminar 8

Seminar Learning Curve Strategy Comparison 8

Harvard Business Review

NOVEMBER 8, 2017

The rising flood of hardware, pharmaceuticals, and technical expertise from American manufacturers and hospital companies, which is connected to the needs of a growing number of hospitals, is also pushing many systems closer to the U.S. Over the same period, pharmaceutical exports have doubled. Transforming Health Care.

Health Care 8

Health Care Tourism Pharmaceuticals Cost 8

Harvard Business Review

MAY 16, 2011

The difference between a partner and a vendor is now well understood by leading practitioners and scholars , yet many companies still proceed into external collaboration with McNealy's blinders. Their challenge then is to learn how to manage these partnerships differently than the vendor relationships they had before.

Software 18

Software Licensing Long-term Telecommunications 18